Warren Buffett and IUDs?; FDA publishes FY16 device fees;

@FierceMedDev: ICYMI Friday: Upstart gets $6M to back the first FDA-cleared, OTC conception assistance device. Article | Follow @FierceMedDev

@VarunSaxena2: ResMed acquires China's Curative Medical to get bigger in sleep disorder devices. Item | Follow @VarunSaxena2

@EmilyWFierce: $OSUR got an FDA OK for emergency use of its rapid Ebola test. Press release | Follow @EmilyWFierce

> Bloomberg takes an in-depth look at the sizable role that billionaire Warren Buffett has played in the popularization of the IUD. Story

> The FDA has published its user fees for medical devices for fiscal 2016. More

> Covidien, now owned by Medtronic ($MDT), has asked the U.S. Supreme Court to take up a ruling against it that would require it to pay $176 million to the Ethicon unit of Johnson & Johnson ($JNJ) regarding violation of a surgical device patent. More

> The FDA may regulate an app for recently released OTC pain device Quell from micro-cap NeuroMetrix ($NURO). Story

Biotech News

@FierceBiotech: ICYMI Friday: Merck's Ebola vaccine is 100% successful in interim Phase III results. Report | Follow @FierceBiotech

@JohnCFierce: Is it just me, or is $SHPG's Ornskov overrated? Shire chief Ornskov bets $300M on another eye drug bolt-on buyout. Story | Follow @JohnCFierce

@DamianFierce: Charming addition to the drug co. nonsense lexicon: "biobetter." More | Follow @DamianFierce

> Sorrento buys into biosimilars with a Chinese antibody deal. Report

> Lexicon rockets up after a positive PhIII study sets up an NDA. Story

> AstraZeneca deepens its Isis ties with a $65M R&D pact. Article

Pharma News

@FiercePharma: ICYMI: Suit says CVS manipulated generic drug prices. Item | Follow @FiercePharma

@EricPFierce: As #Hospira expands recall of #ketorolac to 37M vials you've got to wonder what Pfizer thinks. Article | Follow @EricPFierce

@CarlyHFierce: #ICYMI Friday: Ackman's 'wolf pack' drove Allergan into foreign hands, former CEO says. More | Follow @CarlyHFierce

> Express Scripts stiff-arms AZ's Onglyza, Vivus' Qsymia with new 2016 formulary. Article

> Ex-Teva employee said she got canned for passing info to the feds in Latin America fraud probe. News

Animal Health News

> VCA ups 2015 guidance as Q2 sales and profits soar past expectations. More

> Heska doubles Q2 operating income but misses on revenue. Report

> Schein misses Q2 estimates on currency woes and sales challenges. Story

> IDEXX shares climb on record diagnostics placements and Q2 earnings gain. Article

> Report: 'Precision farming' set to revolutionize livestock care. More

Biotech IT News

> Y Combinator continues push into bioinformatics with investment in Cofactor Genomics. News

> NIH to bankroll initiatives to build Cancer Genomics Cloud Pilots into R&D programs. Report

> Ex-BGI CEO's next move? A $1.6B push to find a 'formula for life.' More

> First startups graduate from Illumina Accelerator as deadline for next phase nears. Story

> Venter's HLI plans to ramp up sequencing capacity as more pharma deals near fruition. Article

Pharma Marketing News

> Express Scripts kicks another batch of meds off its preferred formulary. Item

> Pfizer's hot-selling Ibrance gets even hotter with new $710M sales estimate for 2015. News

> Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode. Story

> Shyft Analytics: Targeted drugs need a data-fueled marketing shift. Article

> Can a dwindling rep tally keep Vivus' obesity med in the game? More